ZDHHC17 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.649800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.127400E-01
Normal-vs-Stage2
3.541100E-03
Normal-vs-Stage3
1.333790E-01
Normal-vs-Stage4
1.407160E-01
Stage1-vs-Stage2
1.535430E-01
Stage1-vs-Stage3
8.207700E-02
Stage1-vs-Stage4
5.617600E-01
Stage2-vs-Stage3
1.765840E-01
Stage2-vs-Stage4
7.771400E-01
Stage3-vs-Stage4
8.030300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.294300E-02
Normal-vs-AfricanAmerican
9.620300E-02
Normal-vs-Asian
3.259000E-03
Caucasian-vs-AfricanAmerican
8.932000E-01
Caucasian-vs-Asian
6.326100E-02
AfricanAmerican-vs-Asian
7.216500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.412000E-02
Normal-vs-Female
7.438500E-03
Male-vs-Female
8.736400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.473600E-01
Normal-vs-Age(41-60Yrs)
7.373600E-02
Normal-vs-Age(61-80Yrs)
1.001550E-02
Normal-vs-Age(81-100Yrs)
1.760820E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.335600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.278400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.063600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.814100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.094220E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.192000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.852240E-01
Normal-vs-Daily Drinker
3.126200E-02
Normal-vs-Weekly Drinker
5.038400E-03
Normal-vs-Occasional Drinker
1.044030E-01
Normal-vs-Social Drinker
2.053000E-01
Non Drinker-vs-Daily Drinker
7.137200E-01
Non Drinker-vs-Weekly Drinker
9.240800E-01
Non Drinker-vs-Occasional Drinker
3.496100E-02
Non Drinker-vs-Social Drinker
1.427850E-01
Daily Drinker-vs-Weekly Drinker
7.168600E-01
Daily Drinker-vs-Occasional Drinker
1.980040E-01
Daily Drinker-vs-Social Drinker
2.521800E-01
Weekly Drinker-vs-Occasional Drinker
8.674400E-02
Weekly Drinker-vs-Social Drinker
1.475240E-01
Occasional Drinker-vs-Social Drinker
9.562400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.410240E-01
Normal-vs-Grade 2
2.577800E-02
Normal-vs-Grade 3
1.752490E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.278800E-01
Grade 1-vs-Grade 3
1.405020E-01
Grade 1-vs-Grade 4
1.410240E-01
Grade 2-vs-Grade 3
9.668000E-01
Grade 2-vs-Grade 4
2.577800E-02
Grade 3-vs-Grade 4
1.752490E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.958700E-03
Normal-vs-NonDiabetic
2.296000E-02
Diabetic-vs-NonDiabetic
5.643800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.629440E-01
Normal-vs-NoPancreatitis
1.404370E-02
Pancreatitis-vs-NoPancreatitis
1.877620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.366200E-02
Normal-vs-N1
3.717400E-03
N0-vs-N1
4.630200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.741610E-01
Normal-vs-TP53-NonMutant
1.942580E-01
TP53-Mutant-vs-TP53-NonMutant
1.198040E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
